Abstract
This study marks the first identification and genomic characterization of Comamonas kerstersii isolates from diarrheal patients in Bangladesh. C. kerstersii is a gram-negative opportunistic bacterium which has also been reported in several clinical samples, including urine, blood, stool, peritoneal liquid, sputum. We carried out the whole genome sequencing of three C. kerstersii isolates for the first time in Bangladesh with an aim to analyze genomic features in 3 different strains isolated from Bangladesh. Seven AMR genes, aph(6)-Id, aph(3’’)-Ib, mph(E), mph(F), msr(E), sul2, and tet(A), have been observed in all the strains. We identified several virulence factors including copper homeostasis genes, type IV pili and type VI secretion system. phage regions and IncQ1 plasmid were also detected.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
North South University
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The North South University (NSU) Institutional Review Board (IRB) / Ethical Review Committee (ERC) approved all experimental protocols, under protocol No. CTRG NSU-RP-20-043.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
